Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

RCUSRCUS
Showing 8 of 30 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in Arcus Biosciences, Inc.

NORTHERN TRUST CORP holds 932,523 shares of RCUS (Arcus Biosciences, Inc.), worth $28.7M as of 2026-Q2. The position was increased (+11.0% shares). RCUS represents 0.0% of NORTHERN TRUST CORP's portfolio.

Current Value

$28.7M

Current Shares

932,523

Total Value Change

+$21M

Total Shares Change

+422,605

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
932,523
+11.0%
$28.7M0.0%$30.83
32
2026-Q1
Increased
840,305
+5.7%
$18.2M0.0%$22.43
30
2025-Q4
Increased
794,798
+12.3%
$18.9M0.0%$23.23
32
2025-Q3
Increased
707,796
+2.4%
$9.6M0.0%$13.32
28
2025-Q2
Increased
691,247
+21.3%
$5.6M0.0%$7.95
32
2025-Q1
Increased
570,042
+7.1%
$4.5M0.0%$8.17
29
2024-Q4
Increased
532,099
+4.3%
$7.9M0.0%$14.91
29
2024-Q3
Increased
509,918
+1.7%
$7.8M0.0%$15.41
28

Other major holders of RCUS: BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used